The role of filaggrin loss-of-function mutations in atopic dermatitis

Current Opinion in Allergy and Clinical Immunology

Volumn 8, Issue 5, 2008, Pages 406-410

  O'Regan, Grainne M ^a   Irvine, Alan D ^a  

^a OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

Atopic dermatitis; Barrier function; Eczema; Filaggrin; Ichthyosis vulgaris; Natural moisturizing factor; Ph; Proteases; Staphyloccus aureus

Indexed keywords

FILAGGRIN; PROTEINASE;

ASTHMA; ATOPIC DERMATITIS; ENVIRONMENTAL FACTOR; EPISTASIS; FLG GENE; GENE; GENE MUTATION; HUMAN; IMMUNOPATHOGENESIS; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; STAPHYLOCOCCUS AUREUS;

DERMATITIS, ATOPIC; GENETIC PREDISPOSITION TO DISEASE; HAND; HUMANS; ICHTHYOSIS VULGARIS; INTERMEDIATE FILAMENT PROTEINS; MUTATION; SKIN PHYSIOLOGY;

EID: 53549098196     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e32830e6fb2     Document Type: Review

References (66)

1. Sandilands A, Terron-Kwiatkowski A, Hull PR, et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet 2007; 39:650-654.
2. Palmer CNA, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38:441-446.
3. Sandilands A, O'Regan GM, Liao H, et al. Prevalent and rare mutations in the gene encoding filaggrin cause ichthyosis vulgaris and predispose to atopic dermatitis. J Invest Dermatol 2006; 126:1770-1775.
4. Barker JN, Palmer CNA, Zhao Y, et al. Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. J Invest Dermatol 2007; 127:564-567.
5. Weidinger S, Illig T, Baurecht H, et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 2006; 118:214-219.
6. Smith FJD, Irvine AD, Terron-Kwiatkowski A, et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet 2006; 38:337-342.
7. Wells RS, Kerr CB. Clinical features of autosomal dominant and sex-linked ichthyosis in an English population. BMJ 1966; 1:947-950.
8. Sybert VP, Dale BA, Holbrook KA. Ichthyosis vulgaris: identification of a defect in synthesis of filaggrin correlated with an absence of keratohyaline granules. J Invest Dermatol 1985; 84:191-194.
9. Presland RB, Boggess D, Lewis SP, et al. Loss of normal profilaggrin and filaggrin in flaky tail (ft/ft) mice: an animal model for the filaggrin-deficient skin disease ichthyosis vulgaris. J Invest Dermatol 2000; 115:1072-1081.
10. Seguchi T, Chang-Yi C, Kusada S, et al. Decreased expression of filaggrin in atopic skin. Arch Dermatol Res 1996; 288:442-446.
11. Irvine AD, McLean WHI. Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis. J Invest Dermatol 2006; 126:1200-1202.
12. Marenholz I, Nickel R, Ruschendorf F, et al. Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol 2006; 118:866-871.
13. Weidinger S, O'Sullivan M, Illig T, et al. Filaggrin mutations, atopic eczema, hay fever and asthma in children. J Allergy Clin Immunol 2008; 121:1203-1209. A comprehensive cohort study documenting the association of filaggrin with the atopic phenotype.
14. Ruether A, Stoll M, Schwarz T, et al. Filaggrin loss-of-function variant contributes to atopic dermatitis risk in the population of Northern Germany. Br J Dermatol 2006; 155:1093-1094.
15. Stemmler S, Parwez Q, Petrasch-Parwez E, et al. Two common loss-offunction mutations within the filaggrin gene predispose for early onset of atopic dermatitis. J Invest Dermatol 2007; 127:722-724.
16. Morar N, Cookson WO, Harper Jl, et al. Filaggrin mutations in children with severe atopic dermatitis. J Invest Dermatol 2007; 127:1667-1672.
17. Gruber R, Janecke AR, Fauth C, et al. Filaggrin mutations R501X and 2282del4 in ichthyosis vulgaris. Eur J Hum Genet 2007; 15:179-184.
18. Brown SJ, Sandilands A, Zhao Y, ef al. Prevalent and low-frequency null mutations in the filaggrin gene are associated with early-onset and persistent atopic eczema. J Invest Dermatol 2008; 128:1591-1594.
19. Brown SJ, Relton CL, Liao H, et al. Filaggrin null mutations and childhood atopic eczema: a population-based case-control study. J Allergy Clin Immunol 2008; 121:940-946.
20. Nomura T, Sandilands A, Akiyama M, et al. Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis. J Allergy Clin Immunol 2007; 119:434-440. Publication of the first Asian filaggrin mutations documented, and reviews the pattern of specific filaggrin mutations emerging worldwide.
21. Nomura T, Akiyama M, Sandilands A, et al. Specific filaggrin mutations cause ichthyosis vulgaris and are significantly associated with atopic dermatitis in Japan. J Invest Dermatol 2008; 128:1436-1441.
22. Chen H, Ho JC, Sandilands A, et al. Unique and recurrent mutations in the filaggrin gene in Singaporean Chinese patients with ichthyosis vulgaris. J Invest Dermatol 2008; 128:1669-1675.
23. Ekelund E, Lieden A, Link J, et al. Loss-of-function variants of the filaggrin gene are associated with atopic eczema and associated phenotypes in Swedish families. Acta Derm Venereol 2008; 88:15-19.
24. Hamada T, Sandilands A, Fukuda S, et al. De novo occurrence of the filaggrin mutation p.R501X with prevalent mutations 3321delA in a Japanese Family with ichthyosis vulgaris complicated by atopic dermatitis. J Invest Dermatol 2008; 128:1323-1325.
25. Candi E, Schmidt R, Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 2005; 6:328-340.
26. Kalinin A, Marekov LN, Steinert PM. Assembly of the epidermal cornified cell envelope. J Cell Sci 2001; 114 (Pt 17):3069-3070.
27. Backendorf C, Hohl D. A common origin for cornified envelope proteins? Nat Genet 1992; 2:91.
28. Pearton DJ, Dale 8A, Presland RB. Functional analysis of the profilaggnn N-terminal peptide: identification of domains that regulate nuclear and cytoplamic distribution. J Invest Dermatol 2002; 119:661-669.
29. Kalinin A, Marekov LN, Steinert PM. Epithelial barrier function: assembly and structural features of the cornified cell envelope. Bioessays 2002; 24:789-800.
30. Koch PJ, de Viragh PA, Scharer D, et al. Lessons from loricrin-deficient mice: compensatory mechanisms maintaining skin barrier function in the absence of a major cornified envelope protein. J Cell Biol 2000; 151:389-400.
31. Djain PK, Easley K, Green H. Targeted ablation of the murine involucrin gene. J Cell Biol 2000; 151:381-388.
32. Sevilla LM, Nachat R, Groot KR, et al. Mice deficient in involucrin, evoplakin and periplakin have a defective epidermal barrier. J Cell Biol 2007; 179:1599-1612.
33. Wong KK, de Leeuw RJ, Dosanjh NS, et al. A comprehensive analysis of common copy-number variations in the human genome. Am J Hum Genet 2007; 80:91-104.
34. Nachat R, Mechin MC, Takahara H, et al. Peptidylarginine deiminase isoforms 1-3 are expressed in the epidermis and involved in the deimination of K1 and filaggrin. J Invest Dermatol 2005; 124:384-393.
35. Rawlings AV, Matts PJ. Stratum comeum moisturization at the molecular level: an update in relation to dry skin cycle. J Invest Dermatol 1994; 124:1099-1100.
36. Kezic S, Kemperman PM, Koster E, et al. Loss-of-function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum corneum. J Invest Dermatol 2008; 128:2117-2119.
37. Scott IR, Harding CR. Filaggrin breakdown to water binding compounds during development of the rat stratum corneum is controlled by the water activity of the environment. Dev Biol 1986; 115:84-92.
38. Krien P, Kermici M. Evidence for the existence of a self-regulated enzymatic process within human stratum corneum-an unexpected role for urocanic acid. J Invest Dermatol 2000; 115:414-420.
39. Schmid-Wendtner MH, Korting HC. The pH of the skin surface and its impact on the barrier function. Skin Pharmcol Physiol 2006; 19:296-302.
40. Elias PM, Hatano Y, Williams ML Basis for the barrier abnormality in atopic dermatitis. J Allergy Clin Immunol 2008; 121:1337-1343.
41. O'Regan GM, Irvine AD, Chen H, et al. The genetic architecture and population genetics of filaggrin-related atopic dermatitis [abstract]. J Invest Dermatol 2008; 128:S128.
42. Baurecht H, Irvine AD, Novak N, et al. Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data. J Allergy Clin Immunol 2007; 120:1406-1412.
43. Ruether A, Stoll M, Schwarz T, et al. Filaggrin loss of function variant contributes to atopic dermatitis risk in the population of Northern Germany. Br J Dermatol 2006; 118:866-871.
44. Henderson J, Northstone K, Lee SP, et al. The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study. J Allergy Clin Immunol 2008; 121:872-877.
45. Basu K, Palmer CN, Lipworth BJ, et al. Filaggrin null mutations are associated with increased asthma exacerbations in children and young adults. Allergy 2008 [Epub ahead of print], doi: S.0.1111/J.1398-9995.2008.01660.x.
46. De Benedetto A, Qualia CM, Baroody FM, Beck LA Filaggrin expression in oral, nasal and esophageal mucosa J Invest Dermatol 2008; 128:1594-1597.
47. Bieber T. Atopic dermatitis. N Engl J Med 2008; 358:1483-1494. A comprehensive review of atopic dermatitis pathogenesis focusing on immunobiological mechanisms.
48. Verhagen J, Akdis M, Traidl-Hoffmann C, et al. Absence of T-regutatory cell expression and function in atopic dermatitis skin. J Allergy Clin Immunol 2006; 117:176-183.
49. Proksch E, Folster-Holst R, Jensen JM. Skin barrier function, epidermal proliferation and differentiation in eczema 1 Dermatol Sci 2006; 43:159-169.
50. Howell MD, Kim BE, Gao P, et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2007; 120:150-155.
51. Ardem-Jones MR, Black AP, Bateman EA, Ogg GS. Bacterial superantigen facilitates epithelial presentation of allergen to T helper 2 cells. Proc Natl Acad Sci U S A 2007; 104:5557-5562.
52. Hudson TJ. Skin barrier function and allergic risk. Nat Genet 2006; 38:399-400.
53. Cookson W. The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat Rev Immunol 2004; 4:978-988.
54. Sonkoly E, Muller A, Lauerma Al, et al. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 2006; 117:411-417.
55. Paus R, Schmeltz M, Biro T, Steinhoff M. Frontiers in pruritus research: scratching the brain for more effective itch therapies. J Clin Invest 2006; 116:1174-1186.
56. Neis MM, Peters B, Dreuw A, et al. Enhanced expression levels of IL-31 con-elate with IL-4 and IL-13 in atopic and allergic contact dermatitis. J Allergy Clin Immunol 2006; 118:930-937.
57. Lomholt H, Anderson KE, Kilian M. Staphyloccus aureus clonal dynamics and virulence factors in children with atopic dermatitis. J Invest Dermatol 2005; 125:977-982.
58. Cork MJ, Robinson DA, Vasilopoulos Y, et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol 2006; 118:3-21.
59. Gilliet M, Soummelis V, Watanabe N, et al. Human dendnitic cells activated by TSLP and CD40L induce proallergenic cytotoxic T cells. J Exp Med 2003; 197:1059-1063.
60. Schauber J, Gallo RL Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol 2008 [Epub ahead of print], doi. 10.10.16/j.jaci.2008.03.027.
61. Walley AJ, Chavanas S, Moffatt MF, et al. Gene polymorphism in Netherton and common atopic disease. Nat Genet 2001; 29:175-178.
62. Vasilopoulos Y, Cork MJ, Murphy R, et al. Genetic association between and AACC insertion of the 3′UTR of the stratum comeum chymotryptic enzyme gene and atopic dermatitis. J Invest Dermatol 2004; 123:62-66.
63. Hubiche T, Ged C, Benard A, et al. Analysis of SPINK5, KLK7 and FLG genotypes in a French atopic dermatitis cohort. Acta Derm Venereol 2007; 87:499-505.
64. Weidinger S, Baurecht H, Wagenpfeil S, et al. Analysis of the individual and aggregate contributions of previously identified SPINK5, KLK7 and FLG polymorphisms to eczema risk. J Allergy Clin Immunol 2008; doi. 10.1016/j.jaci.2008.05.050.
65. Irvine AD. Fleshing out filaggrin phenotypes. J Invest Dermatol 2007; 127:504-507.
66. Strid J, Strobel S. Skin barrier dysfunction and systemic sensensitization to allergens through the skin. Curr Drug Targets Inflamm Allergy 2005; 4:531-541.